Grace K Dy

Trials

Studies that name Grace K Dy as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:55 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07543172 · CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer

  Roswell Park Cancer Institute · not yet recruiting · Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 · principal investigator
• Ph2
  NCT04696575 · Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

  Roswell Park Cancer Institute · recruiting · Extensive Stage Lung Small Cell Carcinoma · principal investigator
• Ph2
  NCT04032418 · Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung Cancer

  Roswell Park Cancer Institute · active not recruiting · Lung Non-Small Cell Carcinoma · principal investigator
• Ph2
  NCT02452463 · Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy

  Roswell Park Cancer Institute · terminated · Lung Non-Squamous Non-Small Cell Carcinoma, Radiation-Induced Pneumonitis, Stage II Lung Non-Small Cell Cancer AJCC v7 · principal investigator
• Ph2
  NCT00951444 · Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

  Alliance for Clinical Trials in Oncology · withdrawn · Lung Cancer · study chair
• Ph2
  NCT00798603 · Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

  Alliance for Clinical Trials in Oncology · completed · Lung Cancer · study chair
• Ph2
  NCT00248495 · Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

  Roswell Park Cancer Institute · completed · Lung Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Administrative Core
  P30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dale Henry · fiscal years 2008 to 2026
  Named on NCT02452463